Legal & General Group PLC Pliant Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 43,258 shares of PLRX stock, worth $489,247. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,258
Previous 41,625 3.92%
Holding current value
$489,247
Previous $620,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$10.58 - $15.61 $17,277 - $25,491
1,633 Added 3.92%
43,258 $465,000
Q1 2024

May 14, 2024
SELL
$14.14 - $19.59 $1,541 - $2,135
-109 Reduced 0.26%
41,625 $620,000
Q4 2023

Feb 15, 2024
SELL
$12.85 - $19.15 $2,364 - $3,523
-184 Reduced 0.44%
41,734 $755,000
Q3 2023

Nov 14, 2023
SELL
$14.58 - $20.15 $6,094 - $8,422
-418 Reduced 0.99%
41,918 $726,000
Q2 2023

Aug 14, 2023
BUY
$18.12 - $30.56 $457,149 - $770,998
25,229 Added 147.48%
42,336 $767,000
Q1 2023

May 15, 2023
BUY
$18.73 - $36.26 $138,246 - $267,635
7,381 Added 75.89%
17,107 $455,000
Q4 2022

Feb 14, 2023
BUY
$17.0 - $25.43 $165,342 - $247,332
9,726 New
9,726 $188,000
Q2 2022

Aug 22, 2022
SELL
$4.11 - $8.75 $23,805 - $50,680
-5,792 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$12.27 - $18.26 $441 - $657
36 Added 0.63%
5,792 $78,000
Q3 2021

Nov 15, 2021
BUY
$16.48 - $28.98 $40,441 - $71,116
2,454 Added 74.32%
5,756 $97,000
Q2 2021

Aug 12, 2021
SELL
$28.05 - $37.69 $476 - $640
-17 Reduced 0.51%
3,302 $96,000
Q1 2021

May 17, 2021
BUY
$24.52 - $40.23 $53,380 - $87,580
2,177 Added 190.63%
3,319 $131,000
Q3 2020

Nov 13, 2020
SELL
$21.54 - $29.53 $83,101 - $113,926
-3,858 Reduced 77.16%
1,142 $26,000
Q2 2020

Aug 14, 2020
BUY
$21.3 - $35.26 $106,500 - $176,300
5,000 New
5,000 $161,000

Others Institutions Holding PLRX

# of Institutions
158
Shares Held
63.8M
Call Options Held
481K
Put Options Held
105K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $551M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email